An extremely positive short CV trial is a big deal. The vaccine is very far from being the savior due to such limited data and resources to roll out on top. I know two nurses who received the vaccine and they know 2 others who have contracted Covid 3 weeks later after receiving first dose. I believe we see an update on data soon showing cases like that as I k ow they are being tracked for big pharma to understand real life data.
Back to my point, if B can stop death that will truly be the silver bullet to this pandemic. A very potent therapeutic for the next 2years and beyond while they get the vaccines rolled out. I bet 40% of this world or more will not get it. Leaving Brilacidin as a blockbuster.
News of great results in this very dark stage can take this price to unthinkable levels IMO. It’s my hope atleast.
News 
Market Data 
Discover 
